Company profile
Abdera Therapeutics company profile
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers. Its targeted radiotherapies utilize purpose-built vectors to specifically target high-energy radio-isotopes to tumors and metastatic cancer lesions. This new class of drugs holds tremendous untapped therapeutic and commercial potential, and has generated over $10B in recent M&A, financings, and product launches – and are expected to comprise 70% of the $30B nuclear medicine market by 2030.
Business identity
- Phone number
- 604.827.1147
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $10K+
- Founded
- 2021-01-01
Headquarters
- Headquarters
- Sydney Forks, Nova Scotia, Canada
- Country code
- CA
- Continent
- North America